Nestlé Sells Blue Bottle at a Loss as Coffee Boom Masks Deeper Portfolio Surgery
26.04.2026 - 00:00:15 | boerse-global.de
The Swiss food giant is selling off a prized coffee asset even as the category powers ahead with double-digit growth — a paradox that cuts to the heart of CEO Philipp Navratil’s turnaround plan. Nestlé has agreed to offload Blue Bottle Coffee to Chinese investment firm Centurium Capital, the same group that controls Luckin Coffee, in a deal that industry insiders value at roughly $400 million. That represents a steep discount on the $700 million Nestlé paid for the specialty chain in 2017.
The transaction covers the café network and packaged bean business, but Nestlé is holding onto the lucrative Nespresso-compatible capsule rights. The sale marks the first concrete step in a broader portfolio shakeout that will see the company slim down to four core pillars: coffee, pet care, nutrition, and food and snacks. Peripheral businesses, including mainstream vitamins and the water division, are also being put under review for potential partnerships or disposals.
Coffee’s Contradiction
The timing of the Blue Bottle exit is striking given the strength of Nestlé’s coffee franchise. The category posted organic sales growth of 9.3 percent in the first quarter, contributing 6 billion Swiss francs in revenue. But Navratil’s logic is clear: capital-intensive retail locations no longer fit a strategy built around globally scalable models. The café chain, while beloved by connoisseurs, simply does not offer the same margin or growth trajectory as Nespresso or Nescafé.
Currency Headwinds Mask Underlying Momentum
Nestlé’s first-quarter numbers, released alongside the Blue Bottle news, reveal a business firing on most cylinders despite a punishing currency backdrop. Reported group sales fell 5.7 percent to 21.3 billion francs, hammered by a strong Swiss franc that cost the company 9.3 percentage points in foreign-exchange losses. Yet organic growth reached 3.5 percent, beating analyst estimates, with real internal volume contributing 1.2 percentage points and pricing adding the rest.
Should investors sell immediately? Or is it worth buying Nestle?
The infant formula recall in China took a 90-basis-point bite out of organic momentum. CEO Navratil said product availability has since been restored, but the company is still working through high inventory levels in Greater China, where organic growth collapsed by double digits. Management aims to have a completely revamped distribution model in place by the end of June.
Cost-Cutting and Job Losses
The strategic overhaul comes with a heavy price tag for employees. Nestlé plans to eliminate around 16,000 positions by the end of 2027 as part of a cost-reduction program targeting 3 billion francs in savings. The restructuring is designed to sharpen focus and improve margins, with the second half of the year expected to deliver a meaningful acceleration in operating profitability.
Analyst Views and Share Price
The market has offered a cautious nod of approval. Deutsche Bank nudged its price target up to 82 francs while maintaining a “Hold” rating. Analyst Tom Sykes acknowledged that the turnaround is on track but argued the valuation leaves little room for upside. Morningstar sees fair value at 88 francs, pointing to Nestlé’s enduring pricing power.
Nestle at a turning point? This analysis reveals what investors need to know now.
The stock closed the week at 81.17 francs, up 2.7 percent from the prior Friday and nearly 8 percent above its 52-week low. Still, the shares remain about 4 percent in the red year-to-date and are trading just below the 200-day moving average. Management is sticking with its full-year guidance for organic sales growth of 3 to 4 percent, a target that will require a strong second-half performance to hit.
Ad
Nestle Stock: New Analysis - 26 April
Fresh Nestle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Nestlé Aktien ein!
Für. Immer. Kostenlos.
